Conmed (CNMD) Intangibles (2010 - 2026)

Conmed's Intangibles history runs 17 years deep, the most recent figure standing at $573.8 million for Q1 2026.

• Quarterly Intangibles fell 5.91% year-over-year to $573.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $573.8 million (down 5.91% YoY) and the FY2025 annual result came in at $582.1 million, down 5.77% from the prior year.
• Intangibles was $573.8 million for Q1 2026 at Conmed, down from $582.1 million in the prior quarter.
• Across five years, Intangibles topped out at $689.5 million in Q3 2022 and bottomed at $463.4 million in Q1 2022.
• A 5-year average of $616.4 million and a median of $625.6 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles fell 6.17% — and 2023, when it surged 45.34%.
• Conmed's Intangibles stood at $681.8 million in 2022, then fell by 4.74% to $649.5 million in 2023, then fell by 4.9% to $617.7 million in 2024, then dropped by 5.77% to $582.1 million in 2025, then fell by 1.42% to $573.8 million in 2026.
• Business Quant data shows CNMD's Intangibles at $573.8 million in Q1 2026, $582.1 million in Q4 2025, and $593.1 million in Q3 2025.